Highside Capital Management
Dallas, Texashighside.com
Overview
Highside Capital Management is a hedge fund sponsor that employs long/short equity strategy to make its investments in the public equity markets of the United States .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mythic Therapeutics | Dec 2021 | Series B | Co-investor |
| InterVenn Biosciences | Aug 2021 | Series C | Co-investor |
| Strata Oncology | Jul 2021 | Series C | Co-investor |
| Lona Biotherapeutics Ltd. | Jun 2020 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
